These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A review of studies published during 1998 examining the treatment and management of benign prostatic obstruction. Frymann R; Cranston D; O'Boyle P BJU Int; 2000 Mar; 85 Suppl 1():46-53. PubMed ID: 10756706 [No Abstract] [Full Text] [Related]
25. The Prostate Trials Office research protocols. Yang Q; Donovan J; Abrams P BJU Int; 2000 Mar; 85 Suppl 1():58-65. PubMed ID: 10756708 [No Abstract] [Full Text] [Related]
26. Can we use baseline characteristics to assess which men with moderately symptomatic benign prostatic hyperplasia at risk of progression will benefit from treatment? A post hoc analysis of data from the 2-year CONDUCT study. Roehrborn CG; Oyarzabal Perez I; Roos EP; Calomfirescu N; Brotherton B; Palacios JM; Vasylyev A; Manyak MJ World J Urol; 2017 Mar; 35(3):421-427. PubMed ID: 27334136 [TBL] [Abstract][Full Text] [Related]
27. Interventional therapies for lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH). Seitz M; Bader M; Tilki D; Stief C; Gratzke C Minerva Urol Nefrol; 2012 Jun; 64(2):123-33. PubMed ID: 22617306 [TBL] [Abstract][Full Text] [Related]
28. [Thermotherapy of benign prostatic hyperplasia]. Höfner K; Krah H; Tan HK; Kuczyk M; Jonas U Urologe A; 1995 Jan; 34(1):16-24. PubMed ID: 7533447 [TBL] [Abstract][Full Text] [Related]
29. Prostatic Artery Embolization (PAE) for Symptomatic Benign Prostatic Hyperplasia (BPH): Part 1, Pathological Background and Clinical Implications. Sun F; Crisóstomo V; Báez-Díaz C; Sánchez FM Cardiovasc Intervent Radiol; 2016 Jan; 39(1):1-7. PubMed ID: 26581418 [TBL] [Abstract][Full Text] [Related]
30. Medical management of BPH: the debate continues. Debruyne FM Eur Urol; 2006 Sep; 50(3):416-7. PubMed ID: 16860460 [No Abstract] [Full Text] [Related]
31. Does Prostate Size Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from the REDUCE Trial. Simon RM; Howard LE; Moreira DM; Roehrborn C; Vidal AC; Castro-Santamaria R; Freedland SJ Eur Urol; 2016 May; 69(5):885-91. PubMed ID: 26724841 [TBL] [Abstract][Full Text] [Related]
33. [Benign prostatic hyperplasia and evidence based medicine: its approach in clinical practice]. Carballido Rodríguez JA; Rodríguez Vallejo JM; del Llano Señaris JE Med Clin (Barc); 2000; 114 Suppl 2():96-104. PubMed ID: 10916816 [TBL] [Abstract][Full Text] [Related]
34. Epidemiology and natural history of benign prostatic hyperplasia. Barry MJ Urol Clin North Am; 1990 Aug; 17(3):495-507. PubMed ID: 1695778 [TBL] [Abstract][Full Text] [Related]
35. Current status of transurethral thermotherapy at the Mayo Clinic. Blute ML; Larson TR; Hanson KA; King BF Mayo Clin Proc; 1998 Jun; 73(6):597-602. PubMed ID: 9621870 [TBL] [Abstract][Full Text] [Related]
36. Novel idea in BPH guideline: the patient as decision maker. Roberts RG Am Fam Physician; 1994 Apr; 49(5):1044-6, 1051. PubMed ID: 7512307 [No Abstract] [Full Text] [Related]
37. Why practical guidelines are required for managing BPH. Kirby R BJU Int; 2003 May; 91(7):592-3. PubMed ID: 12699464 [No Abstract] [Full Text] [Related]
38. Introduction and conclusions. Improving the management of lower urinary tract symptoms in real life practices. Chapple CR Eur Urol; 2001; 39 Suppl 3():1-5. PubMed ID: 11275735 [No Abstract] [Full Text] [Related]
40. [Benign prostatic hyperplasia (BPH): prevalence in general practice and practical approach of French general practitioners. Results of a study based on 17,953 patients]. Costa P; Ben Naoum K; Boukaram M; Wagner L; Louis JF Prog Urol; 2004 Feb; 14(1):33-9. PubMed ID: 15098749 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]